[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Grey Matters Health Inc (GREY.CN)

Grey Matters Health Inc (GREY.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 1,923
  • Shares Outstanding, K 5,418
  • Annual Sales, $ 0 K
  • Annual Income, $ -1,717 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.87
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.06

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3400 +1.47%
on 06/26/26
0.6800 -49.26%
on 06/12/26
-0.0550 (-13.75%)
since 05/26/26
3-Month
0.3350 +2.99%
on 04/29/26
0.6800 -49.26%
on 06/12/26
-0.1550 (-31.00%)
since 03/26/26
52-Week
0.3350 +2.99%
on 04/29/26
0.9000 -61.67%
on 10/31/25
-0.3550 (-50.71%)
since 06/26/25

Most Recent Stories

More News
Grey Matters Announces Increase to Private Placement Financing to $1.25 Million and Closing of Offering

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 18, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company”...

GREY.CN : 0.3550 (unch)
AGNPF : 0.2389 (-6.02%)
Grey Matters Closes First Tranche of $500,000 of its Private Placement Financing

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 05, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company”...

GREY.CN : 0.3550 (unch)
AGNPF : 0.2389 (-6.02%)
Grey Matters Improves Warrant Terms of Private Placement

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 25, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “ Company ”...

GREY.CN : 0.3550 (unch)
AGNPF : 0.2389 (-6.02%)
Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer’s Clinical Trial at 2nd NovaScan Location Planned for Tampa

VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “ Company ” or “ Grey Matters ”) (CSE: GREY) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare...

GREY.CN : 0.3550 (unch)
AGNPF : 0.2389 (-6.02%)
Grey Matters Announces Private Placement

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, April 22, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “ Company...

GREY.CN : 0.3550 (unch)
AGNPF : 0.2389 (-6.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Grey Matters Health Inc is a drug repurposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations, and seeking new regulatory approvals in world-wide markets.

See More

Key Turning Points

3rd Resistance Point 0.3617
2nd Resistance Point 0.3583
1st Resistance Point 0.3567
Last Price 0.3550
1st Support Level 0.3517
2nd Support Level 0.3483
3rd Support Level 0.3467

See More

52-Week High 0.9000
Fibonacci 61.8% 0.6842
Fibonacci 50% 0.6175
Fibonacci 38.2% 0.5508
Last Price 0.3550
52-Week Low 0.3350

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.